Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 January 2021 | Story André Damons | Photo Supplied
Vincent Clarke
Dr Ralph Clark

The Afromontane Research Unit (ARU), the flagship research group of the University of the Free State (UFS) Qwaqwa Campus, has recently been granted R8,4 million to establish a Risk and Vulnerability Science Centre programme.

The Risk and Vulnerability Science Centre (RVSC) programme was established by the Department of Science and Innovation (DSI) as part of the Global Change Research Plan for South Africa and is funded by the DSI through the National Research Foundation (NRF). The RVSC will focus on the need to generate and disseminate knowledge about risk and vulnerability on global change challenges faced by local policy makers/ governance structures and communities in South Africa.

Invited to participate  

Dr Ralph Clark, Director of the ARU, says the UFS, together with the University of Zululand and the Sol Plaatje University, has been invited to participate in Phase 2 of the RVSC programme. Dr Clark was approached by the DSI (on referral from the South African Environmental Observation Network – SAEON) in February 2020 regarding the potential for establishing a RVSC at the UFS Qwaqwa campus.

Subsequent interactions were held between the UFS and DSI, and in March 2020, the UFS formally accepted the DSI invitation. It has since been agreed that the RVSC: UFS will be hosted as a RVSC under the ARU umbrella, with dedicated personnel embedded at the UFS in this regard (internal processes and reporting) but reporting directly to the NRF regarding the RVSC.

Interest and support welcomed

Dr Clark welcomed this interest and support from the DSI-NRF, saying that the funds will further assist the UFS in growing its excellent and growing research portfolio and building more research capacity on this traditionally undergraduate-focused campus. “The RVSC will contribute to much-needed solutions in an area marked by major sustainability challenges and will assist in moving Phuthaditjhaba away from its negative apartheid history towards becoming a sustainable African mountain city,” says Dr Clark.

News Archive

Blood tests for players at FIFA Confederations Cup
2009-03-21

Football stars coming to South Africa to play in the FIFA Confederations Cup tournament in June will not only have their urine tested for illegal substances but their blood as well.

This will be the first time that blood samples from sportsmen or women will be tested in South Africa.

“Blood testing is a new regulation from the World Anti-Doping Agency (WADA) and will be implemented in our laboratory for the FIFA Confederations Cup in June,” according to Dr Pieter van der Merwe, Head of the SA Doping Control Laboratory at the University of the Free State (UFS), the only testing facility of its kind in Southern Africa.

Although urine will still be tested, blood tests have become compulsory, because the substances used by sports men and women are becoming more sophisticated.

“Some substances, such as the growth hormone, can more easily be detected in blood. It is more difficult to determine these kinds of substances in urine,” explained Dr Van der Merwe.

“We were contracted by the International Rugby Board (IRB) to conduct the testing for the 7’s World Cup Rugby Tournament that was recently held in Dubai and by FIFA to do the testing for the Confederations Cup this year as well as the 2010 World Cup. This demonstrates the confidence of International Sport Federations in the quality and standard of work produced by this facility at the UFS,” he said.

The results of all tests done for the national programme in South Africa are sent to the Institute for Drug Free Sport based in Cape Town from where it is reported to the various sports federations. However, the rugby and soccer results are reported directly to the IRB and FIFA respectively.

The move to incorporate blood tests in the testing process has resulted in the expansion of the facility’s infrastructure.

“A new extension will be built for us in the near future in order for us to accommodate the conducting of urine and blood testing,” says Dr van der Merwe.

Media Release
Issued by: Anton Fisher
Director: Strategic Communication
Tel: 051 401 2749
Cell: 072 207 8334
E-mail: fishera.stg@ufs.ac.za  
20 March 2009

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept